Guide on Methodological Standards in Pharmacoepidemiology in China(2nd edition)and their series interpretation(1):an overview
10.12173/j.issn.1004-5511.202412131
- VernacularTitle:《中国药物流行病学研究方法学指南(第2版)》及其系列解读(1):概述
- Author:
Yunxiao WU
1
;
Jinan YAN
;
Xiaolu NIE
;
Houyu ZHAO
;
Siyan ZHAN
;
Feng SUN
Author Information
1. 重大疾病流行病学教育部重点实验室(北京大学)(北京 100191);北京大学公共卫生学院流行病与卫生统计学系(北京 100191)
- Publication Type:Journal Article
- Keywords:
Pharmacoepidemiology;
Methodology;
Guidelines;
Interpretation;
Overview
- From:
Chinese Journal of Pharmacoepidemiology
2025;34(1):2-11
- CountryChina
- Language:Chinese
-
Abstract:
Pharmacoepidemiology is an interdisciplinary discipline that applies epidemiological research methods to evaluate the application and effect of drugs within population.Standardizing pharmacoepidemiological research methods is crucial for ensuring the quality of research and promoting the development of the discipline.The Pharmacoepidemiology Professional Committee of Chinese Pharmaceutical Association developed the Guide on Methodological Standards in Pharmacoepidemiology(1st edition),in 2019,but has not been updated in over five years.Other,countries/regions such as Europe,America,Japan and South Korea have made a lot of progress in developing and updating the guidelines.Therefore,the rapid development of pharmacoepidemiology in our country and the growing need to align with international standards make it essential to update the guidelines.The second edition of the guidelines was developed through a process that included systematic reviews,practical surveys,and multidisciplinary collaboration.Compared with the first edition,the updated version has made many important changes in research design,data sources,specific application scenarios and more,and added new contents such as the application of artificial intelligence.The purpose of this paper is to emphasize the necessity of updating the guidelines,selecting important changes and formulating interpretation plans.It aims to provide references for relevant professionals to comprehensively understand and apply the new guidelines,and to promote the standardized development and quality of pharmacoepidemiologic research in our country,further advancing the field.
